Results 81 to 90 of about 2,731,118 (178)

Novel Terephthalic Acid‐Based Schiff Bases: Synthesis, Biological Evaluation, Molecular Docking, and DFT Studies

open access: yesChemistry &Biodiversity, Volume 23, Issue 11, November 2026.
Four novel terephthalic acid‐based Schiff bases are synthesized and evaluated through biological assays, molecular docking, and DFT calculations. The compounds display antioxidant and enzyme inhibitory activities, with compound 2 showing the most favorable experimental performance and compound 4 exhibiting the strongest predicted binding affinities ...
Kerem Buran   +6 more
wiley   +1 more source

When the Antibiogram Offers Nothing Else: Ceftriaxone–Sulbactam–Disodium EDTA With Intravenous Colistin in Two Neonates With Metallo‐β‐Lactamase‐Producing Acinetobacter baumannii Meningitis

open access: yesClinical Case Reports, Volume 14, Issue 11, November 2026.
ABSTRACT Two neonates with metallo‐β‐lactamase‐producing Acinetobacter baumannii meningitis, resistant to every tested alternative, received ceftriaxone–sulbactam–disodium EDTA plus intravenous colistin, which, to our knowledge, represents the first reported neonatal use of this combinations. Cultures were sterilized by day 7; both survived with normal
Naini Puri   +5 more
wiley   +1 more source

Lon dysfunction-mediated collateral sensitivity drives effective antibiotic combination therapies against tigecycline-resistant pathogens

open access: yesCell Reports
Summary: Tigecycline is a last-resort antibiotic primarily used to treat severe infections caused by multidrug-resistant (MDR) bacteria. However, the emergence of constantly appearing resistance determinants has drastically compromised its clinical ...
Feiyu Yu   +6 more
doaj   +1 more source

High Prevalence of vanA‐Positive Vancomycin‐Resistant Enterococcus faecalis and Enterococcus faecium: Antibiotic Resistance, Biofilm Formation, and Virulence Profiles

open access: yesHealth Science Reports, Volume 9, Issue 11, November 2026.
ABSTRACT Background Data on antimicrobial resistance (AMR), biofilm formation, and virulence traits in clinical Enterococcus isolates from central Iran remain limited. This study evaluated AMR profiles, biofilm‐forming capacity, and the prevalence of virulence and resistance genes in clinical Enterococcus isolates from Arak, Iran.
Rusul Tareq Mezher   +6 more
wiley   +1 more source

Mechanisms and phenotypic consequences of acquisition of tigecycline resistance by Stenotrophomonas maltophilia

open access: yes, 2019
[Objectives]: To elucidate the potential mutation-driven mechanisms involved in the acquisition of tigecycline resistance by the opportunistic pathogen Stenotrophomonas maltophilia.
Martínez, José Luis   +5 more
core   +1 more source

In Vitro Activity of Tigecycline against Multidrug-Resistant Acinetobacter baumannii and Selection of Tigecycline-Amikacin Synergy [PDF]

open access: yesAntimicrobial Agents and Chemotherapy, 2008
ABSTRACT Polymyxin B, minocycline, and tigecycline were the most potent of 10 antibiotics against 170 isolates of multidrug-resistant Acinetobacter baumannii . In time-kill studies, the exposure of a highly tigecycline-resistant isolate to tigecycline resulted in enhanced susceptibility to amikacin and ...
Ellen S, Moland   +6 more
openaire   +2 more sources

Antimicrobial Resistance in Periodontal Disease: Rethinking Adjunctive Therapy in the Metagenomics Era, the Pressing Need for Precision Treatment and Periodontal Resistome Mapping

open access: yesJournal of Cellular and Molecular Medicine, Volume 30, Issue 21, November 2026.
ABSTRACT Systemic antibiotics are effective when used as adjunctive therapy in the treatment of periodontitis; however, their use must be balanced against antimicrobial resistance, which is a major threat to global public health. This review provides an expert synthesis of the literature and a field‐level overview of antimicrobial resistance in ...
Meera Alghafri   +3 more
wiley   +1 more source

Emergence of tigecycline resistance in Escherichia coli co-producing MCR-1 and NDM-5 during tigecycline salvage treatment

open access: yes, 2018
Qian Wang,1 Ping Zhang,2,3 Dongdong Zhao,2 Yan Jiang,2,3 Feng Zhao,4 Yanfei Wang,3 Xi Li,5 Xiaoxing Du,2 Yunsong Yu2,3 1Department of General Practice, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, China; 2Department of ...
Jiang Y   +8 more
core  

A widespread single amino acid mutation in AcrA reduces tigecycline susceptibility in Klebsiella pneumoniae

open access: yesMicrobiology Spectrum
Whole-genome sequencing of a clinical tigecycline non-susceptible Klebsiella pneumoniae strain reveals a novel T188A mutation in AcrA, raising awareness on its role in tigecycline resistance.
Yingchao Xu   +6 more
doaj   +1 more source

Combination of Lenvatinib and Antibiotics: A Potential Approach to Enhance Sensitivity in Differentiated Thyroid Cancer

open access: yesInternational Journal of Cancer, Volume 159, Issue 8, Page 1974-1989, 15 October 2026.
Although lenvatinib is the current first‐line therapy for radioiodine‐refractory differentiated thyroid carcinoma, its use is limited by severe side effects and reduced sensitivity. Here, the authors assessed the potential of sensitizing differentiated thyroid carcinoma tumor cells with limited lenvatinib responsiveness through the administration of ...
Celina Ablinger   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy